Message from the Founder

Since the first successful organ transplant in 1954, organ donation has enabled millions of transplant recipients to live longer, healthier lives.

Unfortunately, to prevent their bodies from rejecting their donor organs, transplant recipients must take powerful immunosuppressive drugs. These drugs have a wide range of side effects, including a weakened immune system, high blood pressure, and a higher risk for medical conditions including diabetes, infections, and cancer.

Transplant recipients deserve better. Using the latest stem cell transplantation technology, ImmunoFree sees an opportunity to drastically improve post-transplant treatment for transplant recipients, enabling them to live longer, healthier lives with their transplanted organs.

Garet Hil, Chairman & CEO
Garet Hil, Chairman & CEO

Founding Centers

  • University of Minnesota

Participating Centers